Monthly View Flat View Weekly View Daily View Categories


June 2019

Friday, June 7, 2019
12:00AM - CV Risk Reduction with SGLT2 Inhibitors and GLP-1 Receptor Agonists: Taking a Closer Look
San Francisco Marriott Marquis • Golden Gate Ballroom A&B, 780 Mission Street • San Francisco, California

In this program, leading diabetes experts ( Chair Dr. Lawrence Leiter, and faculty members Dr. David Cherney, Dr. Melanie Davies, Dr. Darren McGuire, and Davida Kruger, NP) - will provide state-of-the-art information on optimal management of patients with SGLT2 inhibitors and GLP-1 RAs, including latest guideline recommendations, expanding clinical trial evidence, emerging potential mechanistic concepts for cardio-renal benefits, and insights into patient-centered, collaborative care to improve outcomes.


URL: https://www4.cmrreg.com/ada2019/

6:30PM - CV Risk Reduction with SGLT2 Inhibitors and GLP-1 Receptor Agonists: Taking a Closer Look
San Francisco Marriott Marquis • Golden Gate Ballroom A&B, 780 Mission Street • San Francisco, California

In this program, leading diabetes experts ( Chair Dr. Lawrence Leiter, and faculty members Dr. David Cherney, Dr. Melanie Davies, Dr. Darren McGuire, and Davida Kruger, NP) - will provide state-of-the-art information on optimal management of patients with SGLT2 inhibitors and GLP-1 RAs, including latest guideline recommendations, expanding clinical trial evidence, emerging potential mechanistic concepts for cardio-renal benefits, and insights into patient-centered, collaborative care to improve outcomes.


URL: https://www4.cmrreg.com/ada2019/

Sunday, June 9, 2019
6:45PM - Tailoring LDL-C-Lowering Therapy to Patient Cardiovascular Risk: Identifying Effective Strategies
San Francisco Marriott Marquis • Yerba Buena 9-15 • 780 Mission Street • San Francisco, California

In this program, a panel of experts will discuss the latest guidelines for managing LDL-C in patients with diabetes, interpret data with nonstatin, LDL-C-lowering therapies, describe improving access to PCSK9 inhibitors and tips for achieving earlier access, and utilize case presentations to demonstrate best practices for incorporating nonstatin therapy to reduce LDL-C and cardiovascular risk in patients with diabetes.


URL: https://www4.cmrreg.com/ada2019/

Monday, June 10, 2019
6:15PM - Narcolepsy and Excessive Daytime Sleepiness in OSA: Strategies to Improving Outcomes
Grand Hyatt San Antonio • Texas Ballroom A-C, 4th Floor • 600 E Market Street • San Antonio, Texas

In this program, Chair Dr. Richard Bogan and faculty members Dr. Yves Dauvilliers, Dr. Kiran Maski, Dr. Paula Schweitzer, and Dr. Michael Thorpy, will describe the clinical and socioeconomic burden of narcolepsy and discuss strategies to address its burden, explain best practices for determining the cause of EDS in OSA patients, and assess traditional and new therapies for treating patients with narcolepsy and EDS in OSA.


URL: https://www.symposiareg.com/21906/